Profound Medical Corp. ( PROF) - Key Metrics
PROF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.07 | -$0.26 | -$0.31 | -$0.31 |
| 2026Q1 | $0.14 | -$0.19 | -$0.24 | -$0.24 |
| 2025Q4 | $0.19 | -$0.27 | -$0.22 | -$0.22 |
| 2025Q3 | $0.18 | -$0.26 | -$0.32 | -$0.32 |
| 2025Q2 | $0.07 | -$0.52 | -$0.46 | -$0.46 |
PROF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.39 |
| 2026Q1 | 0% | -8.53 |
| 2025Q4 | 0% | -7.29 |
| 2025Q3 | 0% | -4.53 |
| 2025Q2 | 0% | -2.84 |
PROF
Price: $5.84
52 week price:
Earnings Per Share: -0.99 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: Canada
Volume: 115158
Market Capitalization: 212.2 million